BMX and acute myeloid leukemia: The cytoplasmic tyrosine kinase BMX was significantly different in its expression in paediatric AML between standard and low risk subgroups (p = 6.36 × 10−3), and in adults when comparing intermediate and good risk subgroups (p = 5.74 × 10−4).